AusBiotech secures Australian first with world brain mapping congress
AusBiotech is pleased to announce that the 11th Annual World Congress of the Society for Brain Mapping and Therapeutics (SBMT) will be held in Australia for the first time... [+]
Public companies must monitor social media
New ASX disclosure guidelines on monitoring social media for leaks of market-sensitive information herald a new era of reporting compliance, according to Buchan Consulting. [+]
Australian biotech sector grew 7% in 2012
Revenue from the world’s major biotech markets grew 8% in 2012, but weak R&D spending growth is a sign that the sector has still not fully recovered from the GFC,... [+]
Public consultations on Asian Century country strategies
Australia’s position in the Asia-Pacific region, in what has been dubbed the Asian Century, means biotechnology is poised in the right industry in the right region. [+]
Tax reform story not over for biotech industry
Building on the success of the Research and Development (R&D) Tax Incentive, industry leaders are calling for further tax reform to provide incentives for innovative... [+]
AusBiotech secures Australian first with world brain mapping congress
AusBiotech is pleased to announce that the 11th Annual World Congress of the Society for Brain Mapping and Therapeutics (SBMT) will be held in Australia for the first time... [+]
Public companies must monitor social media
New ASX disclosure guidelines on monitoring social media for leaks of market-sensitive information herald a new era of reporting compliance, according to Buchan Consulting. [+]
Australian biotech sector grew 7% in 2012
Revenue from the world’s major biotech markets grew 8% in 2012, but weak R&D spending growth is a sign that the sector has still not fully recovered from the GFC,... [+]
Public consultations on Asian Century country strategies
Australia’s position in the Asia-Pacific region, in what has been dubbed the Asian Century, means biotechnology is poised in the right industry in the right region. [+]
Tax reform story not over for biotech industry
Building on the success of the Research and Development (R&D) Tax Incentive, industry leaders are calling for further tax reform to provide incentives for innovative... [+]
Latest News
- AusBiotech opposes changes to export grants scheme
- Industry Innovation Precincts applications open
- Revised code to benefit ASX-listed life science companies
- Concern over NSW indemnity insurance impact on clinical trials prompts survey
- David Penington to headline AusMedtech Melbourne conference dinner
- Google+
- RSS Feeds
Australian Life Scientist: The Magazine
The magazine for research professionals in the life science and biotech sector across Australia. Click for your FREE subscription